Unilife Corporation has launched Unitract.com to support the commercial release of its Unitract 1 mL clinical safety syringes.
Unilife Corporation announces it has launched www.Unitract.com to support the commercial release of its Unitract 1 mL clinical safety syringes. The Web site contains in-depth product information on Unitracts technology, features and benefits, as well as product variants and availability, a section with downloadable training materials, and videos that provide a detailed look at functionality.
Unitract syringes provide an automatic choice for safe, simple injections. A uniquely passive safety mechanism allows operators to control the rate of needle retraction directly from the body to help protect those at risk of infection from needlestick injuries and aerosol. U.S.-made and intuitive for use, Unitract 1mL syringes are helping to redefine injection safety standards for healthcare workers and patients who self-administer prescription medication.
Silent Saboteurs: Managing Endotoxins for Sepsis-Free Sterilization
Invisible yet deadly, endotoxins evade traditional sterilization methods, posing significant risks during routine surgeries. Understanding and addressing their threat is critical for patient safety.